Nordmark Arzneimittel Gmbh & Co. Kg

Novaliq Gmbh

Daniel Brandhorst

Thierry Berney

Olaf Friedrich

Christian Raemsch

Nicole Raemsch-Guenther

Silke Huettler

Pascal Bucher

Heide Brandhorst

Bernhard Günther

Hasso Meinert

Manfred Kurfürst

Wilfried Hiebl

Manfred Kurfuerst

Bastian Mühling

Nicole Raemsch-Guenter

The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production is mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.

Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof

The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production ia mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.

Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm, for preserving organs or limbs.

Method for preserving organs or limbs using a composition containing a siloxane and a semifluorinated alkane and/or hydrofluoroether

Growing community of inventors

Linden, Germany

Daniel Brandhorst